(Q67840023)

English

Prognostic Significance of Methotrexate and 6-Mercaptopurine Dosage During Maintenance Chemotherapy for Childhood Acute Lymphoblastic Leukemia

scientific article published on 01 October 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1782110%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

Prognostic significance of methotrexate and 6-mercaptopurine dosage during maintenance chemotherapy for childhood acute lymphoblastic leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1782110%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

Prognostic Significance of Methotrexate and 6-Mercaptopurine Dosage During Maintenance Chemotherapy for Childhood Acute Lymphoblastic Leukemia (English)

1 reference

10.3109/08880019109028803

https://api.crossref.org/works/10.3109/08880019109028803

22 November 2022

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.3109/08880019109028803

https://api.crossref.org/works/10.3109/08880019109028803

22 November 2022

author name string

K. Schmiegelow

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1782110

22 November 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1782110

22 November 2022

publication date

1 October 1991

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1782110%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

full work available at URL

http://www.tandfonline.com/doi/pdf/10.3109/08880019109028803

1 reference

10.3109/08880019109028803

https://api.crossref.org/works/10.3109/08880019109028803

22 November 2022

Pediatric Hematology and Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1782110%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1782110%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1782110%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

301-312

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1782110%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

The pharmacology of orally administered chemotherapy. A reappraisal

4

1 reference

10.3109/08880019109028803

https://api.crossref.org/works/10.3109/08880019109028803

22 November 2022

Maintenance chemotherapy for childhood acute lymphoblastic leukemia: relation of bone-marrow and hepatotoxicity to the concentration of methotrexate in erythrocytes

5

1 reference

10.3109/08880019109028803

https://api.crossref.org/works/10.3109/08880019109028803

22 November 2022

6-Thioguanine nucleotide accumulation in red blood cells during maintenance chemotherapy for childhood acute lymphoblastic leukemia, and its relation to leukopenia

6

1 reference

10.3109/08880019109028803

https://api.crossref.org/works/10.3109/08880019109028803

22 November 2022

Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children.

8

1 reference

10.3109/08880019109028803

https://api.crossref.org/works/10.3109/08880019109028803

22 November 2022

Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia

9

1 reference

10.3109/08880019109028803

https://api.crossref.org/works/10.3109/08880019109028803

22 November 2022

White cell count during maintenance chemotherapy for standard-risk childhood acute lymphoblastic leukemia: relation to relapse rate

10

1 reference

10.3109/08880019109028803

https://api.crossref.org/works/10.3109/08880019109028803

22 November 2022

Prognostic importance of myelosuppression during maintenance treatment of lymphoblastic leukaemia. Leukaemia in Childhood Working Party of the Medical Research Council

11

1 reference

10.3109/08880019109028803

https://api.crossref.org/works/10.3109/08880019109028803

22 November 2022

Maintenance chemotherapy for childhood acute lymphoblastic leukemia: should dosage be guided by white blood cell counts?

13

1 reference

10.3109/08880019109028803

https://api.crossref.org/works/10.3109/08880019109028803

22 November 2022

Prognostic significance of hepatotoxicity during maintenance chemotherapy for childhood acute lymphoblastic leukaemia

14

1 reference

10.3109/08880019109028803

https://api.crossref.org/works/10.3109/08880019109028803

22 November 2022

Nonparametric Estimation from Incomplete Observations

17

1 reference

10.3109/08880019109028803

https://api.crossref.org/works/10.3109/08880019109028803

22 November 2022

Dose: a critical factor in cancer chemotherapy

19

1 reference

10.3109/08880019109028803

https://api.crossref.org/works/10.3109/08880019109028803

22 November 2022

Seminars in Oncology

20

14

65

author name string

Hryniuk WM

publication date

1987

1 reference

10.3109/08880019109028803

https://api.crossref.org/works/10.3109/08880019109028803

22 November 2022

Drug dosage and remission duration in childhood lymphocytic leukemia

21

1 reference

10.3109/08880019109028803

https://api.crossref.org/works/10.3109/08880019109028803

22 November 2022

Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia

22

1 reference

10.3109/08880019109028803

https://api.crossref.org/works/10.3109/08880019109028803

22 November 2022

Identifiers

10.3109/08880019109028803

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1782110%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1782110%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67840023&oldid=1776925736"